Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06258226Not yet recruiting
Randomised, single-blind trial (3 arms), sponsored by Wenzhou Central Hospital. Primary endpoints: Estazolam Dosing, Estazolam Dosage Reduction Rate and 2 more. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06258226.